To examine relationships between body mass index (BMI) and coronary risk factors in obese subjects presenting to a dedicated obesity clinic. STUDY DESIGN: Cross-sectional population survey from a single centre. SUBJECTS: Three hundred and eighty-six consecutive non-diabetic obese subjects (301 women, 85 men) attending an obesity clinic for the ®rst time (mean BMI 43.3 kgam 2 ; range 30.6 ± 71.5), aged 17 ± 69 y (mean 40.1). MEASUREMENTS: Height, weight, resting blood pressure, fasting plasma cholesterol, triglyceride, glucose and uric acid concentrations. RESULTS: All variables measured showed an increase with higher BMI (triglycerides, P 0.04; glucose, P 0.007; urate, P`0.001; systolic BP, P`0.001; diastolic BP, P`0.001) as measured by one-way ANOVA, except cholesterol concentration which showed no relationship with BMI. In comparison with the group of subjects with BMI 30 ± 35 kgam 2 mean values for all variables were higher in the more obese subjects. CONCLUSIONS: Non-diabetic subjects with BMI b 35 kgam 2 carry a burden of common coronary risk factors which appears to increase with greater obesity. The risk factor pattern observed echoes that described in insulin resistance syndromes. Plasma cholesterol concentration appears not to be related to BMI.
Introduction
Obesity is associated, for several medical disorders, with potential morbidity and mortality, 1 and is itself regarded as an independent risk factor for coronary heart disease. 2, 3 Although all-cause mortality is known to rise with increasing obesity, it is uncertain to what extent this is related to cardiovascular disease. Much of the increased coronary risk may be related to the high prevalence in obese populations of non-insulin-dependent (type 2) diabetes and may be associated with insulin resistance.
We have reviewed data from consecutive patients attending our obesity clinic to examine associations of obesity with other important coronary risk factors. We have excluded diabetic subjects to avoid this important confounder and have studied subjects across the overweight and obese range of body mass index (BMI).
Subjects and methods
Records from initial assessments of all subjects attending the obesity clinic at this hospital were reviewed. Clinical data for all subjects attending the clinic have been documented since 1991. Available data included details of sex, age, height, weight, and resting blood pressure. Fasting blood samples were taken at the time of ®rst presentation for total cholesterol, triglycerides, glucose and urate measurements, subjects having been admitted to hospital overnight.
Only data from subjects aged between 17 ± 70 y have been included. Subjects for whom inadequate data were available (23 subjects) were excluded. In addition, all subjects with diabetes mellitus or impaired glucose tolerance (43 subjects) were also excluded. A further ®ve subjects were considered to have possible diabetes (taken as a single fasting plasma glucose b 7 mmolal for subjects who did not undergo a glucose tolerance test) and were therefore also excluded from data analysis.
Subjects were divided into groups according to BMI Ð 30 ± 35, 35 ± 40, 40 ± 45, 45 ± 50 and b 50 kgam 2 in order to obtain broadly similarly sized groups. Subjects were matched as closely as possible for age and sex, although the relatively small numbers of men and their unequal distribution in our population meant that complete matching was not possible.
Triglyceride concentrations were log transformed before analysis to stabilise variances. Blood pressure data were calculated only for those subjects not on any relevant drug treatment. We were not able to distinguish truly hypertensive subjects from those using potentially antihypertensive agents for other reasons (eg b-blockers, diuretics, calcium channel antagonists) and so have included all users of such agents when referring to prevalence of drug use.
Statistical analyses were carried out by one-way ANOVA using Microsoft Excel for Windows version 4. The group with BMI of 30 ± 35 kgam 2 was taken as a reference and mean values for the other groups compared with this. Signi®cant Figure 1 Box and whisker plots for systolic (top) and diastolic blood pressure measurements. Horizontal lines represent means, boxes 95% con®dence intervals, and vertical lines interquartile ranges. *P`0.05, **P`0.01, ***P`0.001 for comparison with BMI`35 group.
Obesity and CHD risk factors DC Whitelaw et al differences between means were then estimated from the t distribution. Groups were compared for antihypertensive drug use by w 2 test. The inclusion of some subjects with incomplete biochemical and blood pressure data means that some calculations are based on numbers less than the total number of subjects; missing values have not been replaced.
Results
After exclusion of ineligible subjects as indicated above, data from 386 subjects (301 female, 85 male) were examined. Overall mean BMI was 43.1 kgam 2 (range 30.6 ± 71.5), mean age 40.1 y (range 17 ± 69).
Characteristics of the groups are shown in Table 1 , which summarises mean values for all variables in each group.
Among subjects not on blood pressure lowering treatment both systolic and diastolic blood pressure rose with BMI (Figure 1 ), although examination of the group with BMI 35 ± 40 kgam 2 gave ®ndings of borderline statistical signi®-cance in comparison with the BMI`35 kgam 2 group (for systolic BP P 0.05, for diastolic BPs P 0.07; two-tailed t-test). All other groups showed signi®cantly higher mean blood pressure when compared with the reference group.
When the proportions of subjects in each group on blood pressure lowering treatment were compared these were again signi®cant (by w 2 test P`0.001). There were no signi®cant overall differences between groups for plasma cholesterol concentrations. Comparison of individual group means with that for the BMI`35 kgam 2 group also yielded no signi®cant differences, except that the mean for the highest BMI group (BMI b 50 kgam 2 ) was lower than that in the other groups (P 0.045 compared with the lowest BMI group). Triglyceride concentrations showed an overall upward trend. All groups differed signi®cantly from the reference group. Comparison between groups for cholesterol and triglyceride concentrations are shown in Figure 2 .
Overall comparison for plasma glucose concentration showed a signi®cant trend. All groups had signi®cantly greater mean concentrations than the lowest BMI group. Uric acid concentrations similarly showed a signi®cant upward trend and this appeared to be progressive (Figure 3 ).
Discussion
The role of obesity in cardiovascular risk has been documented from the Framingham Heart Study 2 and, in women, in Obesity and CHD risk factors DC Whitelaw et al the Nurses' Health Study. 4 Not only does obesity appear to be an independent risk factor for coronary heart disease, its association with other risk factors seems to compound that risk.
Several studies have shown a rise in blood pressure with increasing BMI, although its value as a predictor of increased blood pressure (or hypertension) when compared with that of waist-hip ratio (WHR) or other indices of body fat distribution, remains under debate. Among healthy normal to moderately overweight subjects both BMI and WHR have been reported to be equally valid predictors of diastolic hypertension 5 while among healthy normal weight subjects BMI correlates well with both hypertension and declining glucose tolerance. 6 In contrast, among a group of moderately obese women (mean BMI 36 kgam 2 ), BMI was not related to systolic or diastolic blood pressure either on casual or ambulatory measurement, while WHR correlated with both. 7 Data from the Atherosclerosis Risk in Communities (ARIC) Study 8 showed an increasing risk of coronary artery disease as BMI increased, particularly in women, although WHR was a better predictor of risk. Peiris et al 9 found WHR to be a better predictor than total body fat mass of several cardiovascular risk factors and concluded that these relationships may be mediated by hyperinsulinaemia. Elsewhere it has been suggested that noncentral obesity still carries an excess risk; Young and Gelskey 10 found that BMI was at least as important a determinant of blood pressure, and also of LDL-cholesterol, as was WHR. It has been proposed that obesity per se is required in order for the metabolic risk factors associated with abdominal obesity to be expressed. 11 Findings from a large cohort study 3 indicate that overall mortality increases with increasing BMI among obese subjects as do systolic and diastolic blood pressure. In their population, BMI, systolic blood pressure, glucose intolerance (impaired or frank diabetes) and smoking were independent risk factors for premature death.
Several studies, including some cited above, have suggested that plasma cholesterol concentrations are not related to BMI, 3, 9, 11 in agreement with our results. We did not measure waist or hip circumferences in our study population and cannot therefore comment on the role of body fat distribution in relation to the other coronary risk factors measured. Nor did we measure fasting insulin concentrations. However it is interesting to note that the associations observed here are very similar to those described in syndromes of insulin resistance, 12 with hypertension, hypertriglyceridaemia, hyperglycaemia and hyperuricaemia 13 all associated, in the present study, with increasing BMI. Obesity and CHD risk factors DC Whitelaw et al
In conclusion, we have demonstrated an increased burden of coronary risk factors among subjects with a BMI in excess of 35 kgam 2 . In particular we found increased systolic and diastolic blood pressure, increased triglyceride concentrations and higher fasting blood glucose concentrations even within the non-diabetic range. The increases in blood pressure and triglycerides appear not to be linear, although larger epidemiological studies are required to con®rm this. The increased coronary risk in obesity is likely to be mediated by a combination of factors.
